Post-earnings recap
Reported
Wed, Feb 26, 2025
EPS actual
$0.26
EPS est.
$0.37
EPS surprise
-29.73%
1-day move
+3.50%
Corcept Therapeutics reported an EPS of $0.26, which was lower than expected, resulting in a significant negative surprise. Despite the earnings miss, the stock reacted positively, increasing by 3.5%. This could indicate that investors are optimistic about other aspects of the company's performance or future potential.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.26 | N/A | -29.73% |
| Revenue | — | N/A | — |
No transcript is on record for this earnings call, so the analysis is based solely on the numerical results reported.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—